Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001047469-17-002433
Filing Date
2017-04-10
Accepted
2017-04-07 17:54:07
Documents
18

Document Format Files

Seq Description Document Type Size
1 S-1/A a2231698zs-1a.htm S-1/A 1996727
2 EX-3.2 a2231698zex-3_2.htm EX-3.2 34692
3 EX-3.4 a2231698zex-3_4.htm EX-3.4 253604
4 EX-10.1 a2231698zex-10_1.htm EX-10.1 47747
5 EX-10.7 a2231698zex-10_7.htm EX-10.7 799768
6 EX-23.1 a2231698zex-23_1.htm EX-23.1 3599
7 G823840.JPG g823840.jpg GRAPHIC 15173
8 G161350.JPG g161350.jpg GRAPHIC 89744
9 G248340.JPG g248340.jpg GRAPHIC 54773
10 G972037.JPG g972037.jpg GRAPHIC 46866
11 G881286.JPG g881286.jpg GRAPHIC 179755
12 G178708.JPG g178708.jpg GRAPHIC 65596
13 G799768.JPG g799768.jpg GRAPHIC 83640
14 G256830.JPG g256830.jpg GRAPHIC 81517
15 G194287.JPG g194287.jpg GRAPHIC 206420
16 G700374.JPG g700374.jpg GRAPHIC 73675
17 G533242.JPG g533242.jpg GRAPHIC 103362
18 G454073.JPG g454073.jpg GRAPHIC 27830
  Complete submission text file 0001047469-17-002433.txt   4555122
Mailing Address 2855 GAZELLE CT CARLSBAD CA 92010
Business Address 55 CAMBRIDGE PARKWAY SUITE 100 CAMBRIDGE MA 02142 760-603-2732
AKCEA THERAPEUTICS, INC. (Filer) CIK: 0001662524 (see all company filings)

EIN.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-216949 | Film No.: 17750988
SIC: 2834 Pharmaceutical Preparations